(Z)-3-cyano-3-phenylacrylic acid | 756790-25-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (Z)-3-cyano-3-phenylacrylic acid
• 英文别名: 3-cyano-3-phenyl-acrylic acid；3-Cyan-3-phenyl-acrylsaeure；(Z)-3-cyano-3-phenylprop-2-enoic acid
• CAS: 756790-25-7
• 化学式: C₁₀H₇NO₂
• 分子量: 173.171
• InChiKey: ICKZIDPIMZGODJ-RMKNXTFCSA-N

物化性质

• 沸点：
  326.2±31.0 °C(Predicted)
• 密度：
  1.252±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  61.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (Z)-3-cyano-3-phenylacrylic acid 在 四丁基溴化铵 、 碳酸氢钠 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 14.0h， 生成 [(E)-4-[(Z)-3-cyano-3-phenylprop-2-enoyl]oxybut-2-enyl] (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate
  参考文献：
  名称：

  Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity

  摘要：

  To develop novel and efficient heat shock protein 90-cell division cycle 37 (Hsp90-Cdc37) interaction disruptors, several lipophilic fragments were introduced into celastrol (CEL) to synthesize 48 new CEL derivatives. Among all the target compounds, 41 was screened with superior antiproliferative activity on related cancer cells (IC50: 0.41-0.94 mu M) and 41 could decrease the level of the Hsp90-Cdc37 complex in A549 cells. The capability to disrupt the Hsp90-Cdc37 interaction was stronger than that of CEL. Furthermore, pull-down assay, UV assay, and molecular docking analysis all showed that 41 might disrupt the interaction of the Hsp90-Cdc37 complex by preferentially binding to Cdc37 in cancer cells. Further studies showed that 41 could significantly regulate the levels of Hsp90-Cdc37 clients, thereby inducing the apoptosis of cancer cells. Together, 41 is a novel Hsp90-Cdc37 disruptor by binding to Cdc37 (hydrogen bond and/or covalent bond). Our results may provide reference for the discovery of effective Hsp90-Cdc37 disruptors.

  DOI：

  10.1021/acs.jmedchem.9b01290
• 作为产物：
  描述：

  ethyl 3-cyano-3-phenyl-2-propenoate 在 sodium hydroxide 作用下， 生成 (Z)-3-cyano-3-phenylacrylic acid
  参考文献：
  名称：

  Wideqvist, Arkiv foer Kemi, 1952, vol. 3, p. 59,63

  摘要：

  DOI：

文献信息

• [EN] ALLOSTERIC PROTEIN KINASE MODULATORS<br/>[FR] MODULATEURS DE PROTÉINE KINASE ALLOSTÉRIQUE
  申请人：UNIV SAARLAND

  公开号：WO2010043711A1

  公开（公告）日：2010-04-22

  The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

  该发明提供特定的小分子化合物，这些化合物能够变构调节AGC蛋白激酶的活性或调节Aurora家族蛋白激酶的蛋白-蛋白相互作用，提供这些化合物的制备方法，包含这些化合物的药物组合物，以及它们用于制备治疗和预防与AGC蛋白激酶或Aurora家族蛋白激酶异常活动相关疾病的药物的应用。
• ALLOSTERIC PROTEIN KINASE MODULATORS
  申请人：Engel Matthias

  公开号：US20120046307A1

  公开（公告）日：2012-02-23

  The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

  本发明提供了特定的小分子化合物，它们通过变构调节AGC蛋白激酶的活性或调节Aurora家族蛋白激酶的蛋白质-蛋白质相互作用，其生产方法，包含该化合物的药物组合物，以及它们用于制备治疗和预防与AGC蛋白激酶或Aurora家族蛋白激酶异常活动相关疾病的药物的应用。
• Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532
  作者：Chao Liu、Hua Zhou、Xiao Bao Sheng、Xin Hua Liu、Fei Hu Chen

  DOI：10.1016/j.bioorg.2020.104077

  日期：2020.9

  their telomerase inhibitory activity were tested. Among them, eight compounds showed good activity against cancer cells, among them compounds 56, 57 and 59 also showed low toxicity. Some of them showed excellent telomerase inhibitory activity with IC50 values ranging from 0.62 μM to 8.87 μM. Based on above, in depth structure-activity relationships were summarized, the compounds by replacing methyl group

  端粒酶已成为开发抗肿瘤药物的新的流行靶标之一。根据已进入临床研究阶段的BIBR1532的结构特征，设计并合成了6个系列的64种具有不同结构特征的新化合物。测试了对SGC-7901，MGC-803，SMMC-7721，A375和GES细胞系的抑制活性及其端粒酶抑制活性。其中，8个化合物显示良好的活性针对癌细胞，其中化合物56，57和59还显示出低毒性。其中一些对IC 50表现出优异的端粒酶抑制活性值范围从0.62μM到8.87μM。据此，在深度构效关系上进行了总结，用氰化物取代甲基并保留酰胺部分的化合物具有良好的抗肿瘤活性，中等的细胞毒性和较好的端粒酶抑制活性。该结果应在基于BIBR1532的结构优化中用作进一步开发小分子端粒酶抑制剂的参考。
• Stabilization of Organic Materials
  申请人：Gerster Michele

  公开号：US20080269382A1

  公开（公告）日：2008-10-30

  The invention describes a process for stabilizing an organic material against oxidative, thermal or light-induced degradation, which comprises incorporating therein or applying thereto at least a compound of the formula (I) wherein the general symbols are as defined in claim 1 . The compounds of the formula I are especially useful as processing stabilizers for synthetic polymers.

  该发明描述了一种用于稳定有机材料抵抗氧化、热降解或光诱导降解的过程，其中包括将化合物（I）至少混入其中或应用于其中，其中通式中的一般符号如权利要求1所定义。通式I的化合物特别适用作合成聚合物的加工稳定剂。
• Synthesis of coumarins via PIDA/I2-mediated oxidative cyclization of substituted phenylacrylic acids
  作者：Jinming Li、Huiyu Chen、Daisy Zhang-Negrerie、Yunfei Du、Kang Zhao

  DOI：10.1039/c3ra23188g

  日期：——

  A variety of functionalized coumarins were synthesized from substituted phenylacrylic acids via PIDA/I2-mediated and irradiation-promoted oxidative carbon–oxygen bond formation. Our studies show that the oxygen in the pendant carboxylic acid group cyclizes favorably to the aryl ring that is cis to it. The main advantages of this method include good functional group tolerance and the transition-metal-free

  通过PIDA / I 2介导的和辐射促进的氧化碳-氧键形成，由取代的苯基丙烯酸合成了多种功能化的香豆素。我们的研究表明，羧酸侧基中的氧有利地环化成顺式的芳基环。该方法的主要优点包括良好的官能团耐受性和无过渡金属的特性。